{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:53:14Z","timestamp":1777733594836,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["INQUIRY"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>The COVID-19 pandemic enhanced the use of telehealth as a means of delivering services to patients who required continued and uninterrupted care. This helped to reduce readmission to hospitals where COVID-19 hospitalization was prioritized. Patients with HCV and HIV and other chronic diseases require this type of care. This study evaluated the post-pandemic acceptability of pharmacist-delivered telehealth services among HCV and HIV monoinfected and coinfected patients in Washington DC. This was a cross-sectional study conducted in a community pharmacy setting in Washington DC whose primary outcome was the acceptability of pharmacist-delivered telehealth services through a proposed platform(docsink). A validated questionnaire, borrowed from the literature was used to determine telehealth acceptability, measured as behavioral intention, among patients who receive care from this pharmacy. The study recruited 100 participants. Descriptive statistics were conducted as well as bivariable and multivariable analyses to assess predictors of telehealth acceptability. In the unadjusted model, PU\/EM (OR 0.571, 95% confidence interval (0.45-0.73), P\u2009&lt;\u2009.0001)), PEOU(OR 0.72, 95% confidence interval (0.61-0.85)) and IM(OR 0.733, 95% confidence interval (0.62-0.87), P\u2009=\u2009.0003)) were significant predictors of behavioral intention. Overall, the study found that lower Perceived Usefulness\/Extrinsic Motivation scores decrease the odds of intending to use pharmacist-delivered telehealth (OR\u2009=\u20090.490, 95% confidence interval (0.29-0.83), P\u2009=\u2009.008). This study determined that the impact of perceived usefulness and extrinsic motivation was critical to the acceptance of pharmacist-delivered telehealth among a predominantly Black\/African American study population.<\/jats:p>","DOI":"10.1177\/00469580231171338","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:26:25Z","timestamp":1685082385000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["A Cross-Sectional Survey on the Post-Pandemic Acceptability of Pharmacist-Delivered Telehealth Services Among HCV-HIV Patients"],"prefix":"10.1177","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-2723","authenticated-orcid":false,"given":"Rachel K.","family":"Mayaka","sequence":"first","affiliation":[{"name":"Howard University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Awuonda","sequence":"additional","affiliation":[{"name":"Howard University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl","family":"Ettienne","sequence":"additional","affiliation":[{"name":"Howard University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Daftary","sequence":"additional","affiliation":[{"name":"Howard University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u2019Marcus","family":"Wingate","sequence":"additional","affiliation":[{"name":"Howard University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueise","family":"Unonu","sequence":"additional","affiliation":[{"name":"Howard University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"bibr1-00469580231171338","unstructured":"WHO. Hepatitis C, World Health Organization Website. July 9, 2019, Accessed June 20, 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"bibr2-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.012"},{"key":"bibr3-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26218"},{"key":"bibr4-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6371"},{"key":"bibr5-00469580231171338","unstructured":"DC Department of Health Releases. 2019 Annual HIV\/AIDS Epidemiology and Surveillance Report for Washington, DC.| District of Columbia Center for Aids Research | The George Washington University, n.d. Accessed June 21, 2021. https:\/\/dchealth.dc.gov\/sites\/default\/files\/dc\/sites\/doh\/publication\/attachments\/2019%20Annual%20Surveillance%20Report_09062019.pdf"},{"key":"bibr6-00469580231171338","unstructured":"Nina Kim H, Spach DH. Topic 2. Treatment of HCV in Persons with HIV Coinfection.Hepatitis C Online. March 16, 2021. www.hepatitisc.uw.edu\/go\/key-populations-situations\/treatment-hiv-coinfection\/core-concept\/all."},{"key":"bibr7-00469580231171338","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1829"},{"key":"bibr8-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268818000766"},{"key":"bibr9-00469580231171338","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00604"},{"key":"bibr10-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)62001-6"},{"key":"bibr11-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12204"},{"key":"bibr12-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis404"},{"key":"bibr13-00469580231171338","unstructured":"Kim Nina. Lesson 2. Treatment of HCV in Persons with HIV Coinfection. Hepatitis C Online, CDC.gov, 17 February 2021, https:\/\/www.hepatitisc.uw.edu\/go\/key-populations-situations\/treatment-hiv-coinfection\/core-concept\/all#treatment-hiv-persons-hcv-coinfection (accessed June 15, 2021)."},{"key":"bibr14-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.005"},{"key":"bibr15-00469580231171338","unstructured":"DHCF. DC Telemedicine Guide. 2021. https:\/\/dhcf.dc.gov\/sites\/default\/files\/dc\/sites\/dhcf\/page_content\/attachments\/Telemedicine%20Guide%20for%20Medicaid%20Providers%203.25.2020.pdf (accessed June 15, 2021)."},{"key":"bibr16-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.01.019"},{"key":"bibr17-00469580231171338","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4112"},{"key":"bibr18-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1331\/japha.2015.14285"},{"key":"bibr19-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1719"},{"key":"bibr20-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1617"},{"key":"bibr21-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M1475"},{"key":"bibr22-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2014.05.005"},{"key":"bibr23-00469580231171338","unstructured":"Solomon M. Telehealth \u2013 An Opportunity to Expand Pharmacist Services in Primary Care Teleheath expands the role of pharmacists in providing primary care. Disruptive Healthcare. November 20, 2020. https:\/\/www.cedarville.edu\/disruptive-healthcare\/telehealth-an-opportunity-to-expand-pharmacist-services-in-primary-care\/"},{"key":"bibr24-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1177\/1460458219892162"},{"key":"bibr25-00469580231171338","unstructured":"Connect. Fact Sheet. Connect. 2015. Accessed July 5, 2021. https:\/\/connect.dc.gov\/page\/fact-sheet"},{"key":"bibr26-00469580231171338","unstructured":"U.S. Census Bureau, U.S. Census Bureau QuickFacts: District of Columbia. Census Bureau QuickFacts. 2019. Accessed July 5, 2021. https:\/\/www.census.gov\/quickfacts\/fact\/table\/DC\/LFE305219#LFE305219"},{"key":"bibr27-00469580231171338","unstructured":"Weitzman D. Provider status for pharmacists: It\u2019s about time. Pharmacy Times. March 5, 2021. https:\/\/www.pharmacytimes.com\/view\/provider-status-for-pharmacists-its-about-time"},{"key":"bibr28-00469580231171338","doi-asserted-by":"publisher","DOI":"10.1177\/1715163513506370"},{"key":"bibr29-00469580231171338","unstructured":"Sph.UMD. Diffusion of Innovation Theory. Sph.UMD. 2020. Accessed June19, 2021. https:\/\/sphweb.bumc.bu.edu\/otlt\/mph-modules\/sb\/behavioralchangetheories\/behavioralchangetheories4.html"},{"key":"bibr30-00469580231171338","doi-asserted-by":"publisher","DOI":"10.2196\/20786"}],"container-title":["INQUIRY: The Journal of Health Care Organization, Provision, and Financing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00469580231171338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00469580231171338","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00469580231171338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:08:26Z","timestamp":1777460906000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00469580231171338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"alternative-id":["10.1177\/00469580231171338"],"URL":"https:\/\/doi.org\/10.1177\/00469580231171338","relation":{},"ISSN":["0046-9580","1945-7243"],"issn-type":[{"value":"0046-9580","type":"print"},{"value":"1945-7243","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"00469580231171338"}}